Fiche société
Douglas Scharre
Traitements, essais et publications liés.
Traitements6programmes
Essais1liés
Publications10liées
SourceDBlocale
Traitements
6| Molécule | Indication / population | Phase | Objectif | Pays | Résultat |
|---|---|---|---|---|---|
| APOE genotypeThe study is designed to characterize the clinical, neuropsychological, polysomnographic, and neuroimaging findings among subjects with Alzheimer's disease, Lewy Body dementia, and Parkinsons' Disease. | Alzheimer, Parkinson | À vérifier | À vérifier | United States | À vérifier |
| DaTscanThe study is designed to characterize the clinical, neuropsychological, polysomnographic, and neuroimaging findings among subjects with Alzheimer's disease, Lewy Body dementia, and Parkinsons' Disease. | Alzheimer, Parkinson | À vérifier | À vérifier | United States | À vérifier |
| F18-AV-45The study is designed to characterize the clinical, neuropsychological, polysomnographic, and neuroimaging findings among subjects with Alzheimer's disease, Lewy Body dementia, and Parkinsons' Disease. | Alzheimer, Parkinson | À vérifier | À vérifier | United States | À vérifier |
| FDG-PETThe study is designed to characterize the clinical, neuropsychological, polysomnographic, and neuroimaging findings among subjects with Alzheimer's disease, Lewy Body dementia, and Parkinsons' Disease. | Alzheimer, Parkinson | À vérifier | À vérifier | United States | À vérifier |
| PolysomnogramThe study is designed to characterize the clinical, neuropsychological, polysomnographic, and neuroimaging findings among subjects with Alzheimer's disease, Lewy Body dementia, and Parkinsons' Disease. | Alzheimer, Parkinson | À vérifier | À vérifier | United States | À vérifier |
| DaTscanThe study is designed to characterize the clinical, neuropsychological, polysomnographic, and neuroimaging findings among subjects with Alzheimer's disease, Lewy Body dementia, and Parkinsons' Disease. | Alzheimer | À vérifier | À vérifier | United States | À vérifier |
Essais cliniques
1| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| DaTscan | Alzheimer | À vérifier | NCT03019757 | Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease | RECRUITING |
Publications
10| Molécule | Indication / population | Titre | Journal | Date |
|---|---|---|---|---|
| APOE genotype | Astrocytic synapse engulfment is differentially controlled by APOE genotype. | Neuroscience | ||
| APOE genotype | Sex and APOE genotype specific brain regional vulnerability to Alzheimer's Disease. | GeroScience | ||
| APOE genotype | Older adult APOE4 mice exhibit modest immunometabolic adaptation following microglial APOE2 replacement. | Neurobiology of aging | ||
| Polysomnogram | A comparison of therapeutic oxygen versus medical air for the treatment of central sleep apnea in infants with Prader-Willi syndrome; A proof-of-concept randomized crossover trial. | Sleep medicine | ||
| Polysomnogram | Preceding night sleep time and multiple sleep latency test outcomes. | Sleep & breathing = Schlaf & Atmung | ||
| Polysomnogram | International Survey of Growth Hormone and Sleep Evaluation Practices in Infants With Prader-Willi Syndrome. | Clinical endocrinology | ||
| DaTscan | Subtle hypometabolism on [F]FDG-PET, yet absent [I]FP-CIT SPECT binding in a patient with spastic paraplegia type 7. | EJNMMI reports | ||
| DaTscan | Adaptation and feasibility of the International Registry for Alzheimer's Disease and Other Dementias real-world datasets in old-age mental healthcare practice in China. | Journal of Alzheimer's disease : JAD | ||
| DaTscan | Clinical utility of DaTscan in clinically uncertain parkinsonian syndromes: a systematic review and meta‑analysis. | Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia | ||
| F18-AV-45 | Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging. | Alzheimer's & dementia : the journal of the Alzheimer's Association |